Swiss Neonatal Network & Follow-up Group

NCT ID: NCT04239508

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-01

Study Completion Date

2050-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The chief aim of the Swiss Neonatal Network \& Follow-Up Group (SwissNeoNet) is to maintain and / or improve the quality and safety of medical care for high-risk newborn infants and their families in Switzerland through a coordinated program of research, education and collaborative audit. In support of its aim, SwissNeoNet hosts the official medical quality register for the Swiss level III and level IIB units. Participation for these units is mandatory according to the intercantonal declaration for Highly Specialized Medicine (HSM) of September 22, 2011 and the Society's Standards for Levels of Neonatal Care in Switzerland.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inaugurated in 1995, SwissNeoNet now routinely collects data from 9 level III, 10 level IIB and 14 neuro-/developmental pediatric units encompassing information about the care and outcomes of high-risk newborn infants. Data collection is monitored for population coverage, dataset completeness, plausibility and reliability. Data quality is audited within a three year cycle.

Quality improvement

SwissNeoNet releases an annual quality report for participating centers encompassing up to 20 process- and outcome quality indicators. It annually collects data on unit infrastructure evaluated by the Committee for the Accreditation of Neonatology Units (CANU). To discuss quality issues and educational purposes, it hosts bi-annual meetings/symposia for the NEO Directors Group and the Follow-up Group, respectively. The SwissNeoNet member platform offers tools for unit-to-unit quality improvement collaboration (mailing lists, event-organizer, forum, file-sharing and survey builder).

Research

SwissNeoNet coordinates cross-sectional and longitudinal cohort studies that are performed by local researchers using SwissNeoNet's prospectively collected data. These studies focus on mortality, morbidity and/or long-term outcome issues and the analysis of risk factors for development. The network disseminates its research in scientific articles in peer reviewed medical journals.

Support

SwissNeoNet supports the units logistically to ensure that each patient receives primary care (NICU bed availability) and follow-up assessments at 9 to 12 months corrected, 18 to 24 months corrected, and at 5.5 to 6 years of age (FU missing lists) to ensure early diagnosis and intervention. With regards to its Follow-up program, the SwissNeoNet also supports training of new staff and coordinates the launch of new testing instruments between centers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Very Low Birth Weight Infant Very Preterm Maturity of Infant Asphyxia Neonatorum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Minimal Neonatal Dataset MNDS

All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight

No interventions assigned to this group

Below 34, B34

All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight

No interventions assigned to this group

Swiss Asphyxia and Cooling Registry, ASP

Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight


All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight


Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia
Minimum Eligible Age

0 Days

Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Department of Neonatology, Children's Clinic, Cantonal Hospital Aarau, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropaediatrics, Children's Clinic, Cantonal Hospital Aarau, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neonatology, University of Basel Children's Hospital (UKBB), Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropaediatrics and Developmental Medicine, University of Basel Children's Hospital (UKBB), Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Pediatrics, San Giovanni Hospital Bellinzona, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neonatology, University Hospital Berne, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropaediatrics, University Hospital Berne, Switzerland

UNKNOWN

Sponsor Role collaborator

Development and Pediatric Neurorehabilitation Center, Biel, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neonatology, Children's Hospital Chur, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropaediatrics, Children's Hospital Chur, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropediatrics, Cantonal Hospital Fribourg, Switzerland

UNKNOWN

Sponsor Role collaborator

University of Lausanne Hospitals

OTHER

Sponsor Role collaborator

Department of Neonatology, University Hospital Geneva (HUG), Switzerland

UNKNOWN

Sponsor Role collaborator

Division of Development and Growth, University Hospital Geneva (HUG), Switzerland

UNKNOWN

Sponsor Role collaborator

Neonatal and Paediatric Intensive Care Unit, Children's Hospital of Lucerne, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neuropaediatrics, Children's Hospital of Lucerne, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Pediatrics, Cantonal Hospital Muensterlingen, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Pediatrics, Cantonal Hospital Neuchatel, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neonatology, Cantonal Hospital St. Gallen, Switzerland

UNKNOWN

Sponsor Role collaborator

Neonatal and Paediatric Intensive Care Unit, Children's Hospital St. Gallen, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Child Development, Children's Hospital St. Gallen, Switzerland

UNKNOWN

Sponsor Role collaborator

Department of Neonatology, Cantonal Hospital Winterthur, Switzerland

UNKNOWN

Sponsor Role collaborator

Social Pediatrics Center, Cantonal Hospital Winterthur, Switzerland

UNKNOWN

Sponsor Role collaborator

University Hospital, Zürich

OTHER

Sponsor Role collaborator

University Children's Hospital, Zurich

OTHER

Sponsor Role collaborator

Swiss Neonatal Network

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neonatology

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mark Adams, PhD

Role: CONTACT

+41432533034

Dirk Bassler, MD, MSc

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mark Adams, PhD

Role: primary

+41432533034

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PB_2016-02299

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multiperfusion Neonatal System
NCT05058534 COMPLETED